Pediatrix Medical (MD) Net Income towards Common Stockholders (2009 - 2026)

Pediatrix Medical (MD) has reported Net Income towards Common Stockholders for 17 consecutive years, with $29.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 42.61% year-over-year to $29.6 million; the TTM figure through Mar 2026 stood at $179.8 million (up 318.31% YoY), while the FY2025 annual figure was $171.0 million, changed N/A from the prior year.
• Net Income towards Common Stockholders fell to $29.6 million in Q1 2026 per MD's latest filing, from $39.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $71.7 million in Q3 2025 and bottomed at -$153.0 million in Q2 2024.
• Historically, Net Income towards Common Stockholders has averaged $8.1 million across 4 years, with a median of $19.4 million in 2024.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 179.61% — and 2025, when it surged 413.93%.
• Pediatrix Medical's Net Income towards Common Stockholders stood at $5.7 million in 2022, then soared by 438.61% to $30.5 million in 2024, then grew by 28.86% to $39.3 million in 2025, then fell by 24.71% to $29.6 million in 2026.
• Business Quant data shows MD's Net Income towards Common Stockholders at $29.6 million in Q1 2026, $39.3 million in Q4 2025, and $71.7 million in Q3 2025.